We investigated attitudes in lifestyle planning of female medical students concerning career continuation and family life and examined how medical education should support future career decisions. We based our study on the following 3 hypotheses: 1)female medical students already experience anxiety about future pregnancy, child raising, and family life; 2)female medical students are highly conscious of these issues in deciding their future lifestyle; and 3)female medical students who already anticipate leaving their jobs in the future for family life have a strong desire to balance work and family life.
Anonymous, voluntary questionnaires concerning prospective lifestyles and career continuation were distributed to all female medical students (n=806) registered at Tokyo Women's Medical University in 2006. The response rate was 75.3%. The results were analyzed statistically.
While the majority of subjects had concerns regarding pregnancy, giving birth, and family life, they also intended to marry. In addition, 79.3% (n=363) of the subjects wished to give birth, and most gave priority to postgraduate clinical training over having children, thereby choosing to plan their pregnancy around their training. Subjects expected that they would use a child-care center (n=269, 58.7%) for child raising rather than that their partner would take parental leave (n=121, 26.4%). Subjects were divided into 2 groups: those anticipating leaving their job for family issues, and those who did not. According to the χ-square test and discriminant analysis, the former group perceived the role of wife as more positive and significant than did the latter group and had greater anxiety about balancing their family life and their work as a physician.
Medical education to help develop self-esteem and self-control in female medical students is essential, such as providing mentors and access to reproductive health education from an early stage. In addition, active support for career continuation and education to maintain a work-life balance are needed for both men and women.

The treatment by Kampo decoction is partly covered by National Health Insurance in Japan. However, this system is facing bankruptcy crisis because of rising prices of crude drugs in China, their main producer. The board of crude drug materials of the Japan Society for Oriental Medicine (JSOM) distributed questionnaires to 7416 JSOM member doctors, and performed statistical analysis (with JSOM approval) of 1877 answers to visualize the data. Twenty-six percent of respondents said that they had prescribed a decoction, and 29% of respondents said they had not, but wanted to prescribe a crude drug. Eighty-eight percent of doctors who prescribe decoctions offered medical treatment primarily to insured patients. Nine percent offered medical treatment at patients' own expense. The latter group prescribed decoctions more frequently. Many doctors were aware of the financial risk of prescribing crude drugs imposed by the drug price standard and rising crude drug import prices. Four hundred and fifty­-five doctors explained when they were most inclined to prescribe a decoction. Thirty-five percent of these said they used decoctions when they couldn't treat patients with extracts. This result implies a necessity for decoctions. Many doctors said they prescribed decoctions for autoimmune or allergic diseases. Financial constraints were the most frequently cited barrier to treatment with decoctions. This survey made clear the financial difficulties clinics are facing. We therefore calculated the amount of crude drugs used for decoctions to validate the possibility of their domestic production.